This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mactal-Haaf, C. Articles by Kuchta, A. Search for Related Content PubMed PubMed Citation Articles by Mactal-Haaf, C. Articles by Kuchta, A. Social Bookmarking                   What's this?

Use of Anti-Infective Agents During Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics

Department of Pharmacy Practice, M/C 886, University of Illinois at Chicago, 833 S. Wood Street, Room 164, Chicago, IL 60612, USA

Maria Hoffman, PharmD

Ann Kuchta, PharmD

College of Pharmacy at the University of Illinois at Chicago and pharmacotherapists in internal medicine at the University of Illinois at Chicago Medical Center

Because many antibiotics are excreted into the breast milk, it can be difficult for a practitioner to choose an antibiotic for a lactating patient that will have minimal risks to her nursing infant. This article is the last of a three-part series discussing the use of anti-infective agents during lactation. The authors review general information with regard to use and common side effects for several classes of antibiotics. They summarize information, including available safety data, documented milk concentrations, milk-to-plasma ratios, and other pharmacokinetic properties, to help practitioners choose antibiotics that may be considered safe to use in the lactating mother.

Key Words: lactation • breastfeeding • human milk • anti-infectives

References

• Chin KG, Mactal-Haaf C, McPherson CE. Use of anti-infective agents during lactation, part 1: beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid. J Hum Lact. 2000;16: 352-359.
• Keating MR. Antiviral agents for non-human immunodeficiency virus infections: symposium on antimicrobial agents, part XV. Mayo Clin Proc. 1999;74:1266-1283.[Abstract]
• Famvir [package insert]. Philadelphia: SmithKline Beecham; 1999.
• Lau RJ, Emery MG, Galinsky RE. Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. Obstet Gynecol. 1987;69:468-471.[Web of Science][Medline] [Order article via Infotrieve]
• Meyer LJ, Miranda P, Sheth N, Spruance S. Acyclovir in human breast milk. Am J Obstet Gynecol. 1988;158:586-588.[Web of Science][Medline] [Order article via Infotrieve]
• Bork K, Benes P. Concentration and kinetic studies of intravenous acyclovir in serum and breast milk of a patient with eczema hepericum. J Am Acad Dermatol. 1995;32:1053-1055.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Takemoto CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 6th ed. Cleveland, OH: Lexicomp; 1999.
• Taddio A, Klein J, Koren G. Acyclovir excretion in human breast milk. Ann Pharmacother. 1994;28:585-587.[Abstract]
• American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93: 137-150.[Abstract/Free Full Text]
• American Society of Health-System Pharmacists. Antivirals. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000:2495-2497.
• Hale T. Medications and Mothers' Milk. 8th ed. Amarillo, TX: Pharmasoft Medical; 1999.
• Nora JJ, Nora AH, Way GL. Cardiovascular maldevelopment associated with maternal exposure to amantadine. Lancet. 1975;2:607-607.
• Relenza [package insert]. Research Triangle Park, NC: GlaxoWellcome; 2000.
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Baltimore, MD: Williams & Wilkins; 1998.
• Van de Perre P. Postnatal transmission of human immunodeficiency virus type 1: the breast-feeding dilemma. Am J Obstet Gynecol. 1995; 173:483-487.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Patel R. Antifungal agents, part I: amphotericin B preparations and flucytosine. Mayo Clin Proc. 1998;73:1205-1225. Symposium on Antimicrobial Agents, Part 3.[Abstract]
• Parfitt K, ed. Martindale: The Complete Drug Reference. London: Pharmaceutical Press; 1999.
• Flucytosine [package insert]. Nutley, NJ: Roche; 1998.
• Griseofulvin [package insert]. Raritan, NJ: Ortho Pharmaceutical Corporation; 1997.
• Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents: drug interactions of clinical significance. Drug Saf. 1998;2:83-97.
• McClellan KJ, Wiseman LR, Markham A. Terbinafine: an update of its use in superficial mycoses. Drugs. 1999;58:179-202.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lamisil [package insert]. East Hanover, NJ: Novartis; 1999.
• Terrell CL. Antifungal agents, part II: the azoles. Mayo Clinic Proc. 1999;74:78-100. Symposium on Antimicrobial Agents, Part 4.[Abstract]
• Kappe R. Antifungal activity of the new azole UK-109,496 (voriconazole). Mycoses. 1999;42(suppl 2):83-86.[Medline] [Order article via Infotrieve]
• Schilling CG, Sea RE, Larson TA. Excretion of fluconazole in human breastmilk. Pharmacotherapy. 1993;13:287-287. Abstract 130.
• Force RW. Fluconazole concentrations in breastmilk. Pediatr Infect Dis J. 1995;14:235-236.[Web of Science][Medline] [Order article via Infotrieve]
• Debruyne D. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. Clin Pharmacokinet. 1997;33:52-77.[Web of Science][Medline] [Order article via Infotrieve]
• Zichella. Excretion of itraconazole in human breast milk. Unpublished case report; Janssen Research Foundation; 1990.
• Force RW, Nahata M. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother. 1995;29:10-15.[Abstract]
• Moretti ME, Ito S, Koren G. Disposition of maternal ketoconazole in breast milk. Am J Obstet Gynecol. 1995;173:1625-1626.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Van Lint J, De Doncker P, Woestenborghs R. Chronic use of 2% ketoconazole shampoo in patients with seborrheic dermatitis and dandruff. Curr Ther Res. 1988;43:43-47.
• Ene MD, Williamson PJ, Daneshmend TK. Systemic absorption of ketoconazole from vaginal pessaries. Br J Clin Pharmacol. 1984; 17:173-175.[Web of Science][Medline] [Order article via Infotrieve]
• Sabo JA, Abdel-Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother. 2000;34:1032-1043.[Abstract]
• American Society of Health-System Pharmacists. Antivirals. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000:3159-3193.
• Ernest JM. Topical antifungal agents. Obstet Gynecol Clin North Am. 1992;19:587-607.[Web of Science][Medline] [Order article via Infotrieve]
• Docampo R, Moreno SN. The metabolism and mode of action in gentian violet. Drug Metab Rev. 1990;22:161-178.[Web of Science][Medline] [Order article via Infotrieve]
• Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses: a North American perspective. Drugs. 1998;55:645-674.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wilhelm MP, Edson RS. Antimicrobial agents in urinary tract infections. Mayo Clin Proc. 1987;62:1025-1031.[Web of Science][Medline] [Order article via Infotrieve]
• Eichenwald HF. Antimicrobial therapy in infants and children: update 1976-1985 (part II). J Pediatr. 1985;107:337-345.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr. 1973;82:886-887.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pons G, Rey E, Richard MO, et al. Nitrofurantoin in human milk. Dev Pharmacol Ther. 1990;14:148-152.[Web of Science][Medline] [Order article via Infotrieve]
• Hosbach RE, Foster RB. Absence of nitrofurantoin from human milk. JAMA1967;202:1057-1057.[Abstract/Free Full Text]
• Rehm SJ, McHenry MC. Oral antimicrobial drugs. Med Clin North Am1983;67:57-98.[Web of Science][Medline] [Order article via Infotrieve]
• Allgen LG, Holmberg G, Persson B, Sorbo B. Biological fate of methenamine in man: absorption, renal excretion and passage to umbilical cord blood, amniotic fluid and breast milk. Acta Obstet Gynecol Scand. 1979;58:287-293.[Web of Science][Medline] [Order article via Infotrieve]
• Berger H. Excretion of mandelic acid in breast milk. Am J Dis Child. 1941;61:256-261.
• Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997;53:637-656.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Human Lactation, Vol. 17, No. 2, 160-166 (2001)
DOI: 10.1177/089033440101700214


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mactal-Haaf, C. Articles by Kuchta, A. Search for Related Content PubMed PubMed Citation Articles by Mactal-Haaf, C. Articles by Kuchta, A. Social Bookmarking                   What's this?